Literature DB >> 10611293

The alpha-helical FXXPhiPhi motif in p53: TAF interaction and discrimination by MDM2.

M Uesugi1, G L Verdine.   

Abstract

Transcriptional activation domains share little sequence homology and generally lack folded structures in the absence of their targets, aspects that have rendered activation domains difficult to characterize. Here, a combination of biochemical and nuclear magnetic resonance experiments demonstrates that the activation domain of the tumor suppressor p53 has an FXXPhiPhi motif (F, Phe; X, any amino acids; Phi, hydrophobic residues) that folds into an alpha-helix upon binding to one of its targets, hTAF(II)31 (a human TFIID TATA box-binding protein-associated factor). MDM2, the cellular attenuator of p53, discriminates the FXXPhiPhi motif of p53 from those of NF-kappaB p65 and VP16 and specifically inhibits p53 activity. Our studies support the notion that the FXXPhiPhi sequence is a general alpha-helical recognition motif for hTAF(II)31 and provide insights into the mechanistic basis for regulation of p53 function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10611293      PMCID: PMC24728          DOI: 10.1073/pnas.96.26.14801

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Histone-like TAFs within the PCAF histone acetylase complex.

Authors:  V V Ogryzko; T Kotani; X Zhang; R L Schiltz; T Howard; X J Yang; B H Howard; J Qin; Y Nakatani
Journal:  Cell       Date:  1998-07-10       Impact factor: 41.582

2.  GLI activates transcription through a herpes simplex viral protein 16-like activation domain.

Authors:  J W Yoon; C Z Liu; J T Yang; R Swart; P Iannaccone; D Walterhouse
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

3.  A nonnatural transcriptional coactivator.

Authors:  O Nyanguile; M Uesugi; D J Austin; G L Verdine
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

4.  Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions.

Authors:  I Radhakrishnan; G C Pérez-Alvarado; D Parker; H J Dyson; M R Montminy; P E Wright
Journal:  Cell       Date:  1997-12-12       Impact factor: 41.582

5.  Recruitment of p300/CBP in p53-dependent signal pathways.

Authors:  M L Avantaggiati; V Ogryzko; K Gardner; A Giordano; A S Levine; K Kelly
Journal:  Cell       Date:  1997-06-27       Impact factor: 41.582

6.  Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

Authors:  W Gu; R G Roeder
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

7.  Solution conformation of an essential region of the p53 transactivation domain.

Authors:  M V Botuyan; J Momand; Y Chen
Journal:  Fold Des       Date:  1997

8.  DNA-dependent protein kinase acts upstream of p53 in response to DNA damage.

Authors:  R A Woo; K G McLure; S P Lees-Miller; D E Rancourt; P W Lee
Journal:  Nature       Date:  1998-08-13       Impact factor: 49.962

9.  Histone-like TAFs are essential for transcription in vivo.

Authors:  B Michel; P Komarnitsky; S Buratowski
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

10.  DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.

Authors:  S Y Shieh; M Ikeda; Y Taya; C Prives
Journal:  Cell       Date:  1997-10-31       Impact factor: 41.582

View more
  44 in total

1.  Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes.

Authors:  Penny G Ard; Chandrima Chatterjee; Sudeesha Kunjibettu; Leon R Adside; Lisa E Gralinski; Steven B McMahon
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

2.  The basic helix-loop-helix differentiation factor Nex1/MATH-2 functions as a key activator of the GAP-43 gene.

Authors:  Martine Uittenbogaard; Debra L Martinka; Anne Chiaramello
Journal:  J Neurochem       Date:  2003-02       Impact factor: 5.372

3.  A self-consistent phase-field approach to implicit solvation of charged molecules with Poisson-Boltzmann electrostatics.

Authors:  Hui Sun; Jiayi Wen; Yanxiang Zhao; Bo Li; J Andrew McCammon
Journal:  J Chem Phys       Date:  2015-12-28       Impact factor: 3.488

4.  Multivalent binding of p53 to the STAGA complex mediates coactivator recruitment after UV damage.

Authors:  Armin M Gamper; Robert G Roeder
Journal:  Mol Cell Biol       Date:  2008-02-04       Impact factor: 4.272

5.  Hitting on the move: Targeting intrinsically disordered protein states of the MDM2-p53 interaction.

Authors:  Constantinos G Neochoritis; Jack Atmaj; Aleksandra Twarda-Clapa; Ewa Surmiak; Lukasz Skalniak; Lisa-Maria Köhler; Damian Muszak; Katarzyna Kurpiewska; Justyna Kalinowska-Tłuścik; Barbara Beck; Tad A Holak; Alexander Dömling
Journal:  Eur J Med Chem       Date:  2019-08-06       Impact factor: 6.514

6.  Transient protein states in designing inhibitors of the MDM2-p53 interaction.

Authors:  Michal Bista; Siglinde Wolf; Kareem Khoury; Kaja Kowalska; Yijun Huang; Ewa Wrona; Marcelino Arciniega; Grzegorz M Popowicz; Tad A Holak; Alexander Dömling
Journal:  Structure       Date:  2013-10-24       Impact factor: 5.006

7.  Mutation of mouse p53 Ser23 and the response to DNA damage.

Authors:  Zhiqun Wu; John Earle; Shin'ichi Saito; Carl W Anderson; Ettore Appella; Yang Xu
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

8.  Walleye dermal sarcoma virus rv-cyclin inhibits NF-kappaB-dependent transcription.

Authors:  Sandra L Quackenbush; Ashley Linton; Connie D Brewster; Joel Rovnak
Journal:  Virology       Date:  2009-01-26       Impact factor: 3.616

9.  p53 modulates the activity of the GLI1 oncogene through interactions with the shared coactivator TAF9.

Authors:  Joon Won Yoon; Marilyn Lamm; Stephen Iannaccone; Nicole Higashiyama; King Fu Leong; Philip Iannaccone; David Walterhouse
Journal:  DNA Repair (Amst)       Date:  2015-08-01

10.  p53 Amino-terminus region (1-125) stabilizes and restores heat denatured p53 wild phenotype.

Authors:  Anuj Kumar Sharma; Amjad Ali; Rajan Gogna; Amir Kumar Singh; Uttam Pati
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.